CR Bard, AngioDynamics Spar Over Timing Of Damages Trial
By Adam Lidgett ( December 12, 2022, 7:21 PM EST) -- C.R. Bard and AngioDynamics have laid out different time frames on when a Delaware federal court should schedule a damages trial after a jury last month found AngioDynamics' implantable port products infringed Bard's patents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.